PRAMEF14

PRAME family member 14 Q5SWL7 PRA14_HUMAN
Protein Coding Chr 1 1p36.21 Swiss-Prot reviewed Entrez 729528
Mutations
88
CL 4 · Tissue 84
Samples
83
CL 4 · Tissue 79
Peptides
56
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations88484
Samples83479
Peptides56353

Function

PRAMEF14 · PRAME family member 14

Predicted to be involved in several processes, including negative regulation of apoptotic process; negative regulation of transcription, DNA-templated; and positive regulation of cell population proliferation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000334600 Q5SWL7 88 56

Gene Properties

Type
Protein Coding
Chromosome
1
Cytoband
1p36.21
Entrez ID

Recurrent Mutations

All 56 amino-acid changes on canonical ENST00000334600 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in PRAMEF14 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in PRAMEF14 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
Melanoma
1/210 0%
12/1899 1%
Squamous Cell Lung Carcinoma
0/57 0%
5/810 1%
Esophageal Squamous Cell Carcinoma
0/51 0%
10/2550 0%
Hepatocellular Carcinoma
1/46 2%
7/2210 0%
Gastric Carcinoma
0/74 0%
6/1809 0%
Endometrial Carcinoma
0/42 0%
2/612 0%
Bladder Carcinoma
0/58 0%
3/956 0%
Non-Small Cell Lung Carcinoma
2/304 1%
3/1390 0%
Neuroendocrine Tumour
0/154 0%
2/577 0%
Small Cell Lung Carcinoma
0/9 0%
2/752 0%
Other Blood Cancers
0/61 0%
7/2725 0%
Cervical Carcinoma
0/35 0%
1/422 0%
Head and Neck Carcinoma
0/85 0%
3/1574 0%
Colorectal Carcinoma
0/143 0%
6/3239 0%
Breast Carcinoma
0/144 0%
4/3264 0%
B-Cell Non-Hodgkins Lymphoma
0/88 0%
3/2534 0%
Ovarian Carcinoma
0/109 0%
1/998 0%
Other Solid Cancers
0/94 0%
1/1515 0%
Glioma
0/52 0%
1/2127 0%

Mutation Distribution

Where PRAMEF14 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in PRAMEF14 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 1 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 88 mutations in PRAMEF14

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide